Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion type Assertion NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_head.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion description "[Tumor cell with disruption of these cell cycle regulators can get a growth advantage and metastatic potential during tumor progression, especially p16/CDKN2 alterations may be associated with lymph node metastasis in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_provenance.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion evidence source_evidence_literature NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_provenance.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion SIO_000772 11295092 NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_provenance.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion wasDerivedFrom befree-20140225 NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_provenance.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion wasGeneratedBy ECO_0000203 NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_provenance.